| Laminin-511 and laminin-521-based matrices for efficient hepatic specification of human pluripotent stem cells LK Kanninen, R Harjumäki, P Peltoniemi, MS Bogacheva, T Salmi, ... Biomaterials 103, 86-100, 2016 | 78 | 2016 |
| SARS‐CoV‐2–host proteome interactions for antiviral drug discovery X Liu, S Huuskonen, T Laitinen, T Redchuk, M Bogacheva, K Salokas, ... Molecular Systems Biology 17 (11), e10396, 2021 | 64 | 2021 |
| Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery M Bogacheva, A Egorova, A Slita, M Maretina, V Baranov, A Kiselev Bioorganic & Medicinal Chemistry Letters 27 (21), 4781-4785, 2017 | 26 | 2017 |
| Differences in definitive endoderm induction approaches using growth factors and small molecules MS Bogacheva, S Khan, LK Kanninen, M Yliperttula, AW Leung, YR Lou Journal of cellular physiology 233 (4), 3578-3589, 2018 | 21 | 2018 |
| Challenges for the applications of human pluripotent stem cell-derived liver organoids M Chang, MS Bogacheva, YR Lou Frontiers in Cell and Developmental Biology 9, 748576, 2021 | 20 | 2021 |
| Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible Three-Dimensional Cell Culture Systems: Possibilities and Limitations MS Bogacheva, R Harjumäki, E Flander, A Taalas, MA Bystriakova, ... Frontiers in Cell and Developmental Biology 9, 726499, 2021 | 6 | 2021 |
| Thyroid hormone effect on the differentiation of human induced pluripotent stem cells into hepatocyte-like cells MS Bogacheva, MA Bystriakova, YR Lou Pharmaceuticals 14 (6), 544, 2021 | 4 | 2021 |
| RNA-based CRISPR-mediated loss-of-function mutagenesis in human pluripotent stem cells AW Leung, C Broton, MS Bogacheva, AZ Xiao, MI Garcia-Castro, YR Lou Journal of molecular biology 432 (13), 3956-3964, 2020 | 3 | 2020 |
| Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome MS Bogacheva, S Kuivanen, S Potdar, A Hassinen, S Huuskonen, ... Antiviral Research 223, 105813, 2024 | 1 | 2024 |
| Nanobody engineering for SARS-CoV-2 neutralization and detection L Hannula, S Kuivanen, J Lasham, R Kant, L Kareinen, M Bogacheva, ... Microbiology Spectrum, e04199-22, 2024 | 1 | 2024 |
| NSP15 inhibitors repurposing for SARS-CoV-2 NAM Al-Rashedi, M Bogacheva, HAT Alburkat, MG Munahi, BK Salman, ... Virology, 2023 | | 2023 |
| Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible MS Bogacheva, R Harjumäki, E Flander, A Taalas, MA Bystriakova, ... Stem cells in Tissue Homeostasis and Disease, 2022 | | 2022 |
| Nanobody engineering for SARS-CoV-2 neutralization and detection (preprint) L Hannula, S Kuivanen, J Lasham, R Kant, L Kareinen, M Bogacheva, ... | | 2022 |
| The influence of soluble components and culture conditions on hepatic differentiation of human pluripotent stem cells M Bogacheva Helsingin yliopisto, 2021 | | 2021 |
| Pluripotent stem cells differentiation towards definitive endoderm M Bogacheva, L Kanninen, YR Lou Toxicology Letters 314, S186-S187, 2019 | | 2019 |
| Peptide-mediated anti-VEGF siRNA delivery targeting angiogenesis in glioblastoma and endothelial cells A Shubina, A Egorova, M Bogacheva, M Maretina, V Baranov, A Kiselev HUMAN GENE THERAPY 24 (12), A70-A70, 2013 | | 2013 |
| Study of modular peptide-based vechicles for targeted gene delivery MS Bogacheva, AN Shubina, MA Maretina, AA Egorova, AN Slita, ... HUMAN GENE THERAPY 24 (12), A63-A63, 2013 | | 2013 |
| A receptor-mediated gene delivery system using CXCR4 ligand-conjugated cross-linking peptides AA Egorova, AV Kiselev, MS Bogacheva, VS Baranov Drug Discovery Today 15 (23), 1105, 2010 | | 2010 |
| Development of non-viral gene delivery system using CXCR4 ligand-conjugated cross-linking peptides A Kiselev, A Egorova, M Bogacheva, V Baranov HUMAN GENE THERAPY 21 (10), 1409-1409, 2010 | | 2010 |
| XVIII Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) October 22–25, 2010 Milan, Italy T Cathomen, T VandenDriessche, A Aartsma-Rus, GJB van Ommen, ... Human Gene Therapy, 1357-1499, 2010 | | 2010 |
